The FDA authorized IceCure Medical's ProSense system for specific indications.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA authorized IceCure Medical's ProSense system for specific indications.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
IceCure Medical
Nothing else this week.
Related events
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- Ondine Biomedical Inc. is seeking a pre-NDA meeting with the FDA regarding LANTERN results while conducting clinical trials in the US and Canada.
- EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.